hence in creatinine concentration on the calcium/ creatinine ratio. As the effect of diet cannot be disregarded all tests were made on fasting subjects, and, to exclude any effect from diurnal variations, the tests were performed between 0600 and 1200 hours.
After overnight urine concentration, an oral water load was given to induce diuresis and provide specimens with a relatively wide range of creatinine concentration for each subject.
232 urine specimens were collected from 26 normal subjects and in these subjects the fasting calcium/creatinine ratio was found to be independent of the urine creatinine concentration. 122 urine specimens were collected from 10 patients with primary hyperparathyroidism, and 62 urine specimens from 8 patients with hypercalcremia due to other causes. In 8 of the 10 patients with primary hyperparathyroidism and in 2 of the 8 with hypercalcemia due to other causes, ratios were found to be high when the creatinine concentration was low but normal when the creatinine concentration was high.
The results suggest that negative tests for hypercalciuria should not be accepted in the interpretation of a random urine sample if the urine creatinine level is more than 40 mg/loo ml. It may well be that measures of 24 hour urine calcium output are similarly affected by urine concentration.
Magnesium and Serum Alkaline Phosphatase
D. N. BARON THE ROYAL FREE HOSPITAL, LONDON The King-Armstrong procedure, usually used in the United Kingdom for the assay of serum alkaline phosphatase, employs phenylphosphate as a substrate. Buch and Buch (1939) showed that magnesiumtt (lmM) causes activation of this enzyme reaction by about 30%. Magnesium also causes the activation of the enzyme as measured by the procedures of Bodansky, which uses glycerophosphate, and of Bessey, Lowry and Brock, which uses p-nitrophenyl phosphate.
We have confirmed progressive activation of serum alkaline phosphatase by Mg rt, which reaches a plateau when the concentration of Mg++ in the buffer-substrate is about 0·5 mM, using the modified phenylphosphate manual procedure of King and Wootton (1956) and AutoAnalyser procedure of Bell and Collier (1964) . Activation of the enzyme in sera from patients with liver disease averaged 33 % and similar results were obtained from patients with osteoblastic bone disease. Chelation of Mg++ by EDTA progressively removed the serum alkaline phosphatase activity, this being almost complete at 7·5 mg. EDTA/m!. serum. It is suggested that Mg++ be added-to ImM concentration-for all assays of serum alkaline phosphatase.
